Single Center Experience of Mesothelioma Patients in Southeast Region of Turkey
dc.contributor.author | Cil, Timucin | |
dc.contributor.author | Isikdogan, Abdurrahman | |
dc.contributor.author | Onat, Serdar | |
dc.contributor.author | Zincircioglu, Burhanettin | |
dc.contributor.author | Ulku, Refik | |
dc.contributor.author | Ozekinci, Selver | |
dc.contributor.author | Ates, Gungor | |
dc.date.accessioned | 2024-04-24T17:38:05Z | |
dc.date.available | 2024-04-24T17:38:05Z | |
dc.date.issued | 2009 | |
dc.department | Dicle Üniversitesi | en_US |
dc.description.abstract | Malignant mesothelioma (MM) is an aggressive tumor, which was originated from serous membranes. The most frequent malignant mesothelioma types are originated from pleura, peritoneum, tunica vaginalis of testis and pericardium respectively. The most frequent etiologic factor is asbestosis but rarely radiation or fibrous zeolit have been etiologic factors. MM is endemically present in some regions of Turkey including several provinces in the southeast region of the country, as a result of exposure to environmental fibrous minerals. We were analysed demographic principals, treatment options, chemotherapy protocols and treatment responses of 45 MM patients retrospectively who presented at the medical oncology division of the Dicle University Hospital in Turkey between 2004 and 2007. When we were retrospectively analysed our patients; 13 (28%) of them have been living in city center and 32 (72%) have been living in rural area. We saw any treatment responses; 6 (26%) in platin-gemcitabine and 5 (31.25%) in platin-pemetrexed were detected. In southeast region of Turkey, prevalence of MM is more than other regions of Turkey and also it is an important disease for southeast region of Turkey. Chemotherapy have been used for paliative treatment in MM. Treatment responses are very low with new agents in the literature. However, treatment responses in our patients are worse than literature. | en_US |
dc.identifier.endpage | 158 | en_US |
dc.identifier.issn | 1306-133X | |
dc.identifier.issue | 3 | en_US |
dc.identifier.scopus | 2-s2.0-72949084833 | |
dc.identifier.scopusquality | Q4 | |
dc.identifier.startpage | 153 | en_US |
dc.identifier.uri | https://hdl.handle.net/11468/21318 | |
dc.identifier.volume | 19 | en_US |
dc.identifier.wos | WOS:000271596100005 | |
dc.identifier.wosquality | N/A | |
dc.indekslendigikaynak | Web of Science | |
dc.indekslendigikaynak | Scopus | |
dc.language.iso | tr | en_US |
dc.publisher | Akad Doktorlar Yayinevi | en_US |
dc.relation.ispartof | Uhod-Uluslararasi Hematoloji-Onkoloji Dergisi | |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Cancer | en_US |
dc.subject | Mesothelioma | en_US |
dc.subject | Chemotherapy | en_US |
dc.title | Single Center Experience of Mesothelioma Patients in Southeast Region of Turkey | en_US |
dc.title | Single Center Experience of Mesothelioma Patients in Southeast Region of Turkey | |
dc.type | Article | en_US |